Clear Labs is a provider of a fully-automated sequencing platform for turnkey diagnostics.
Clear Labs harnesses the power of next-generation sequencing to simplify complex diagnostics for clinical and applied markets by creating a fully automated platform that brings together dna sequencing, robotics, and cloud-based analytics clear labs democratize genomics applications to deliver increased clarity.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 30, 2018 | Series B | $21M | 1 | — | — | Detail |